S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
ADGM$0.0888+2.07%
Adagio Medical Holdings, Inc.
Sector: Surgical & Medical Instruments & ApparatusIndustry: Medical - DevicesCountry: USExchange: Nasdaq
Mkt Cap:$2.44M
Float & O/S:
Inst Own:
DilutionScan read 37 of Adagio Medical Holdings, Inc.'s SEC filings and found 6 warrant series, 1 convertible, 1 shelf registration, 2 S-1 registrations and 1 completed offering on file for ADGM. The latest dilution event on file is a conversion repricing on Sep 23, 2026. Analysis updated Oct 31, 2026.
Signal8 Summary
ADGM
Cash-strapped micro-cap facing delisting
Snapshot
Adagio Medical is a pre-revenue medical device company developing heart-ablation catheters, with FY 2025 revenue effectively at zero and a net loss of $25.1M.
What's Happening Right Now
- : Q2 2026 net loss was $6.7M with no revenue due to a pause in European sales, and cash fell from $17.1M to $7.7M, tightening the company's financial runway.
- : Adagio treated its first patient with a next-generation faster ablation catheter under FDA expanded access and got approval to expand its ongoing heart-rhythm trial to test it.
- : At its June 16, 2026 annual meeting, shareholders elected two directors and ratified the company's accounting firm for fiscal 2026.
- : Nasdaq warned Adagio that its stock has traded below the $1.00 minimum price for 30 days straight, starting a 180-day clock to fix it or risk delisting.
Raise routes on file: effective shelf + effective S-1 · latest dilution event 41 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Sep 23, 2026 · Conversion Price Reset
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2024
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
2025 PIPE Pre-Funded Warrants
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
S-3 shelf registration
Issued 2025
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
PIPE
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your ADGM trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
